|
1
|
Schuster H, Kinnan S. Catatonia Associated With Valbenazine Treatment. J Clin Psychopharmacol 2023; Publish Ahead of Print:00004714-990000000-00151. [PMID: 37335215 DOI: 10.1097/jcp.0000000000001722] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 06/21/2023]
|
|
2
|
Abstract
A quality improvement project was delivered by a federally qualified health center to improve patient access to psychiatric services. The effort was supported by training and technical assistance provided by the American Psychiatric Association Support and Alignment Network. Over a 3-year period, the collaborative care model (CoCM) and other integrated consultative strategies were implemented. As a result, the waitlist was reduced from 350 patients to 1 patient. The use of the CoCM and other integrated care strategies was successful in eliminating a psychiatric service waitlist in this primary care setting.
Collapse
Affiliation(s)
- Shannon Kinnan
- Department of Psychiatry, Creighton University School of Medicine, and OneWorld Community Health Center, Omaha (Kinnan); College of Nursing, University of Nebraska Medical Center, Omaha (Emerson); Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle (Kern, Ratzliff). Benjamin G. Druss, M.D., M.P.H., and Gail Daumit, M.D., M.H.S., are editors of this column
| | - Margaret R Emerson
- Department of Psychiatry, Creighton University School of Medicine, and OneWorld Community Health Center, Omaha (Kinnan); College of Nursing, University of Nebraska Medical Center, Omaha (Emerson); Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle (Kern, Ratzliff). Benjamin G. Druss, M.D., M.P.H., and Gail Daumit, M.D., M.H.S., are editors of this column
| | - John Kern
- Department of Psychiatry, Creighton University School of Medicine, and OneWorld Community Health Center, Omaha (Kinnan); College of Nursing, University of Nebraska Medical Center, Omaha (Emerson); Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle (Kern, Ratzliff). Benjamin G. Druss, M.D., M.P.H., and Gail Daumit, M.D., M.H.S., are editors of this column
| | - Anna Ratzliff
- Department of Psychiatry, Creighton University School of Medicine, and OneWorld Community Health Center, Omaha (Kinnan); College of Nursing, University of Nebraska Medical Center, Omaha (Emerson); Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle (Kern, Ratzliff). Benjamin G. Druss, M.D., M.P.H., and Gail Daumit, M.D., M.H.S., are editors of this column
| |
Collapse
|
|
3
|
Affiliation(s)
- Venkata Kolli
- Department of Psychiatry, Creighton University, 3528 Dodge Street, Omaha, Nebraska, 68131. .,Department of Psychiatry, Creighton University, Omaha, Nebraska, USA
| | - Anureet Walia
- Creighton Psychiatry Residency Program, Omaha, Nebraska, USA
| | - Shannon Kinnan
- Department of Psychiatry, Creighton University, Omaha, Nebraska, USA
| |
Collapse
|
|
4
|
Abstract
Initiatives to develop better-tolerated, more efficacious pharmacological agents with improved drug delivery systems have driven recent research in attention-deficit hyperactivity disorder (ADHD). While stimulants are the primary pharmacotherapy for ADHD, these drugs have a limited duration of action and a subset of patients will either fail to respond to these medications or have side effects that preclude their use. The development of atomoxetine, the first nonstimulant approved for ADHD, has been followed by additional innovative research, such as the methylphenidate transdermal system, modafinil, NRP-104 and cholinergic agents. This review highlights some of the recent trends in ADHD treatment and the current status of promising treatment options that may help to shape the future of ADHD treatment.
Collapse
Affiliation(s)
- Vishal Madaan
- Child and Adolescent Psychiatry, Creighton University-University of Nebraska Medical Center, Omaha, NE, USA.
| | | | | | | |
Collapse
|